Learn more about the ongoing damage in sickle cell disease and the impact of vaso-occlusive crises

You are now leaving the Novartis site and moving to an external website independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for the site. If you do not wish to leave this site, click Cancel. Or click "OK" to continue.